Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis. (August 2016)

• Record Type: Journal Article
• Authors: Botta, Eliana; Meroño, Tomás; Saucedo, Carla; Martín, Maximiliano; Tetzlaff, Walter; Sorroche, Patricia; Boero, Laura; Malah, Verónica; Menafra, Martín; Gómez Rosso, Leonardo; Chapman, John M.; Kontush, Anatol; Soriano, Enrique; Brites, Fernando
• Is Part Of: Atherosclerosis. Volume 251(2016)
• Page Start: 438
• Page End: 444
• Publication Date: 2016-08
• Subjects: Rheumatoid arthritis -- HDL -- Paraoxonase -- Cholesteryl ester transfer protein -- Pulse wave velocity -- Arterial rigidity -- Atherosclerosis; Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2016.06.009
• Languages: English
• ISSNs: 0021-9150

Abstract

Abstract: Background and aims: Rheumatoid arthritis (RA) is a chronic, inflammatory disease associated with increased risk of cardiovascular disease (CVD). Measures of HDL metabolism/function were shown to be altered in RA patients with high disease activity. We aimed at evaluating the effect of HDL characteristics on arterial stiffness in RA patients classified according to the inflammatory disease activity. Methods: RA patients were classified according to disease activity (DAS-28) into active RA (n = 27; DAS-28 > 3.2) and inactive RA patients (n = 17; DAS-28 < 3.2). A control group of healthy individuals was also studied (n = 33). Clinical and biochemical characteristics, cholesteryl ester transfer protein (CETP) and paraoxonase 1 (phenylacetate and paraoxonase) activities and carotid-femoral pulse wave velocity (cf-PWV) were determined. Results: Anthropometric characteristics were similar in all groups. In accordance with the inflammatory status, active RA patients presented elevated hsCRP levels ( p < 0.001). There were no differences in the lipid profile between groups. Similarly, features of insulin resistance were absent in RA patients ( p = non-significant). Active RA patients presented higher CETP activity than the other two groups ( p = 0.026). Phenylacetate and paraoxonase activities were altered in active RA patients in comparison with the other groups ( p = 0.034 and p = 0.041, respectively). Cf-PWV was significantly higher in active RA patients in comparison with controls, following adjustment by age ( p = 0.030). Age (βst = 0.468, p = 0.013) and apo A-I levels (βst = −0.405, p = 0.029) were independent predictors of cf-PWV in a model including hsCRP, HOMA-IR, and phenylacetate activity (r 2 = 0.42). Conclusions: High DAS-28 identifies patients with alterations in HDL characteristics. Plasma levels of apo A-I can be used as a marker of arterial stiffness in RA. Highlights: RA patients with disease activity-score (DAS)-28 > 3.2 showed altered markers of HDL functionality and arterial stiffness. Apolipoprotein A-I levels were independently associated with arterial stiffness in normolipemic RA patients. Apolipoprotein A-I might be useful for assessment of vascular health in RA.